The Alexandra General Hospital is a General hospital in central Athens, Greece. It was established in 1954, initially as a Maternity Hospital and later as a Maternity & Obstetrics - Gynecological Hospital. It is located at Vassilisis Sofias avenue in the center of Athens.

There are 350 beds in 'Alexandra' Hospital.

During the past decade, 'Alexandra' Hospital conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 20 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 11 clinical trials were completed. i.e. 40.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "'Alexandra' Hospital" #1 sponsor was "Amgen" with 8 trials, followed by "Alexandra Hospital, Athens, Greece" with 6 trials sponsored, "Celgene" with 6 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored and "Janssen Research & Development, LLC" with 6 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "'Alexandra' Hospital" #1 collaborator was "AbbVie" with 2 trials as a collaborator, "Alexandra Hospital, Athens, Greece" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator and "Amgen" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "'Alexandra' Hospital" are "Multiple Myeloma" (15 trials), "Neoplasm Metastasis" (4 trials), "Amyloidosis" (3 trials), "Breast Neoplasms" (3 trials) and "AL Amyloidosis" (2 trials). Many other conditions were trialed in "'Alexandra' Hospital" in a lesser frequency.

Most popular intervention types in "'Alexandra' Hospital" are "Drug" (63 trials), "Biological" (6 trials), "Other" (6 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (17 trials), "Placebo" (13 trials), "Daratumumab" (7 trials), "Carfilzomib" (6 trials) and "Lenalidomide" (6 trials). Other intervention names were less common.

The vast majority of trials in "'Alexandra' Hospital" are 64 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "'Alexandra' Hospital". undefined are not yet recruiting, 23 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 28 completed trials in 'Alexandra' Hospital, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in 'Alexandra' Hospital, 4 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".